Company profile for BioSense Global, LLC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

In 2015, BioSense was established to address the business needs of the global biopharmaceutical market with a focus on China, Europe, and the U.S. The organization’s mission is to bridge the gap between undercapitalized biopharmaceutical projects, companies, and investors. BioSense’s expert team of international biopharma executives and investors offer cross-cultural expertise and advisory while navigating entry into new m...
In 2015, BioSense was established to address the business needs of the global biopharmaceutical market with a focus on China, Europe, and the U.S. The organization’s mission is to bridge the gap between undercapitalized biopharmaceutical projects, companies, and investors. BioSense’s expert team of international biopharma executives and investors offer cross-cultural expertise and advisory while navigating entry into new markets and access to additional resources and funds. BioSense’s interests are divided into two sectors: Research and Development and Investment

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
1 Meadowlands Plaza, Suite 800, East Rutherford, NJ 07073
Telephone
Telephone
(201) 636.6309
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.jnj.com/media-center/press-releases/biosense-webster-begins-enrollment-of-pivotal-trial-evaluating-the-laminar-left-atrial-appendage-elimination-device

PRESS RELEASE
27 Feb 2024

https://johnsonandjohnson.gcs-web.com/static-files/0e678f48-2902-4a73-836d-8d6c1c0b53c0

PRESS RELEASE
04 Aug 2023

https://johnsonandjohnson.gcs-web.com/static-files/34578c13-fa3d-4ec5-8b92-c1c6674de93b

PRESS RELEASE
13 Oct 2022

https://www.globenewswire.com/news-release/2019/04/16/1804668/0/en/Rexahn-and-BioSense-Global-Announce-Collaboration-and-License-Agreement-for-RX-3117-in-Greater-China.html

GLOBENEWIRE
16 Apr 2019

https://seekingalpha.com/article/4211487-week-review-biosense-exercises-75-million-option-china-rights-neovacs-lupus-immunotherapy

SEEKING ALPHA
15 Oct 2018

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty